需要冰片市場(chǎng)調(diào)查報(bào)告 包括市場(chǎng)份額、產(chǎn)量、生產(chǎn)、提純技術(shù)、藥用占比等等多維度數(shù)據(jù)   [更多]

找生物醫(yī)藥醫(yī)療器械的企業(yè)有項(xiàng)目需要辦公研發(fā)生產(chǎn)的場(chǎng)地。有公司名稱(chēng)就可以。 我這邊能聯(lián)系到公司確定后可獲得賞金   [更多]

https://journal.pda.org/content/41/3/88.short 要求完整的版本。   [更多]

需要“馬栗種子提取物片 X19990265 Dr.Willmar Schwabe ”的標(biāo)準(zhǔn) 標(biāo)準(zhǔn)來(lái)源： 藥品復(fù)核標(biāo)準(zhǔn)匯編1999年   [更多]

重組蛋白發(fā)酵、純化、檢測(cè)全套SOP資料   [更多]

一類(lèi)醫(yī)療器械“醫(yī)用冷敷貼”的產(chǎn)品備案和生產(chǎn)備案全套資料（word版本）   [更多]

1，涉及委托生產(chǎn)及委托研發(fā)類(lèi)的，MAH整套的管理制度，報(bào)告，記錄 2，中文word文檔   [更多]

1.Title：Studies of the polymorphism of sodium valproate. (Ger.). Authors：Kleinebudde P; Thies R Publication Name：Sci.Pharm. Publication Year：1999 Keywords：Valproate Sodium/Oc Crystal/Ft Polymorphism/Ft Calorimetry/Ft X-Ray- Diffraction/Ft Analysis/Ft Crystallography/Ft Anticonvulsants/Ft Antimanics / Ft Oc / Ft Extract：2 Crystal modifications (M1 and M2) of Na valproate (NV) have been detected at RT, while a further form (M3) occurred at temperatures above 100 deg. Untreated NV, which had been recrystallized from toluene or ethyl acetate occurred as modification M1. These modifications were examined by thermoanalytical (DSC, thermogravimetry) and X-ray crystallographic methods. 2.【題名】Polymorphism of sodium valproate 【作 者】Mifsud, H.;Miguel, L.;Lavastre, V.;Maire, G. 【刊 名】Calorim. Anal. Therm. Calorimetrie et Analyse Thermique 【出版日期】1993 【卷 號(hào)】Vol.24 【頁(yè) 碼】309-312 【關(guān)鍵詞】polymorphism sodium valproate Polymorphism of sodium valproate 1069-66-5 polymorphism 【摘 要】Polymorphism anal. is of fundamental pharmaceutical importance for correct development of a drug, as it provides valuable knowledge of its biopharmaceutical and technol. aspects. Indeed, different polymorphs exhibit different phys. properties that can affect bioavailability. Polymorphism screening has been developed in the authors' lab., based on crystn. parameter variations for a given drug in soln. Sodium valproate is an anti-epileptic drug commercialized under the name Depakine. Five polymorphic forms were obtained by the screening and characterized by differential scanning calorimetry, X-ray powder diffractometry, thermogravimetry and IR spectroscopy. The relationships between these forms were examd.   [更多]

本公司臨床部門(mén)需要一份比較完善且新的針對(duì)臨床試驗(yàn)全過(guò)程的質(zhì)量管理體系文件。符合2020版GCP法規(guī)要求，如果內(nèi)容滿(mǎn)足要求費(fèi)用可以追加。   [更多]

需符合《新藥品管理法》、《新藥品注冊(cè)管理辦法》等相關(guān)新法律法規(guī)。完全符合者共計(jì)200rmb酬金，50rmb為部分酬金。 舉例： 質(zhì)量管理制度中供貨單位審核管理制度? ? ? ? 改 根據(jù)新藥品管理法要求修訂內(nèi)容，收集的資料內(nèi)容需調(diào)整，取消收集GMP、GSP證書(shū)等。 舉例2： 質(zhì)量管理制度?中不合格藥品管理制度? ? ? ? ?改 根據(jù)新藥品管理法要求修訂內(nèi)容，調(diào)整假劣藥定義，增加無(wú)公害處理的內(nèi)容等?。 舉例3：。。。。。。。。   [更多]